JG
RPRX icon

Jain Global’s Royalty Pharma RPRX Stock Holding History

Jain Global’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-66,353
Closed -$3.18M – 2000
2026
Q1 		$3.18M Sell
66,353
-299,077
-82% -$13.1M 0.01% 584
2025
Q4 		$14.1M Buy
+365,430
New +$13.9M 0.07% 274
2025
Q3 		– Sell
-50,153
Closed -$1.81M – 1430
2025
Q2 		$1.81M Buy
50,153
+25,000
+99% +$828K 0.01% 522
2025
Q1 		$783K Buy
+25,153
New +$797K 0.01% 476

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jain Global's RPRX Position: Q2 2026 in Review

Jain Global sold out of Royalty Pharma (RPRX) in Q2 2026, closing a stake of 66,353 shares — an estimated $3.18M sold.

Jain Global first reported a position in RPRX in Q1 2025 and held it in 4 quarters. The position peaked at $14.1M in Q4 2025. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Jain Global reported no remaining Royalty Pharma position as of Q2 2026 after selling out during the quarter.
  • Jain Global sold 66,353 Royalty Pharma shares in Q2 2026, an estimated $3.18M.
  • Jain Global first reported a position in Royalty Pharma in Q1 2025 and held it in 4 quarters.
  • Jain Global's Royalty Pharma position peaked at $14.1M in Q4 2025.
  • 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.